CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
Scripps Research Institute |
Dr. Jeanne F Loring |
Conference |
World Stem Cell Summit |
$30,000 |
University of California, Davis |
Dr. Alice F Tarantal |
Conference |
12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases |
$8,000 |
Stanford University |
Dr. Julien Sage |
Conference |
3rd International RB conference |
$10,000 |
Lineage Cell Therapeutics, Inc. |
Francois Binette |
Strategic Partnership III Track A |
A Phase I/IIa Dose Escalation Safety Study of AST-OPC1 in Patients with Cervical Sensorimotor Complete Spinal Cord Injury |
$14,323,318 |
City of Hope, Beckman Research Institute |
Prof. John A. Zaia |
Strategic Partnership III Track A |
A Phase I, Open-Label Study To Assess The Safety, Feasibility and Engraftment of Zinc Finger Nucleases (ZFN) CCR5 Modified Autologous CD34+ Hematopoietic Stem/Progenitor Cells (SB-728MR-HSPC) with Escalating Doses of Busulfan In HIV-1 (R5) Infected Sub… |
$5,583,438 |
University of California, Santa Cruz |
Dr. Joshua M Stuart |
Genomics Centers of Excellence Awards (R) |
Center of Excellence for Stem Cell Genomics – UCSC |
$3,999,083 |
Salk Institute for Biological Studies |
Dr. Joseph R Ecker |
Genomics Centers of Excellence Awards (R) |
Center of Excellence for Stem Cell Genomics – Salk |
$13,201,635 |
Stanford University |
Dr. Michael P Snyder PhD |
Genomics Centers of Excellence Awards (R) |
Center of Excellence for Stem Cell Genomics – Stanford |
$22,787,914 |
Stanford University |
Dr. Robert Robbins |
Disease Team Planning |
{REDACTED} Cardiovascular Regenerative Team |
$25,119 |
University of California, San Diego |
Dr. Dennis Carson |
Disease Team Planning |
CIRM Planning Grant in Leukemia |
$52,174 |
City of Hope, Beckman Research Institute |
Dr. Michael E. Barish Ph, D. |
Disease Team Planning |
Genetically-modified neural stem cells for treatment of high-grade glioma |
$55,000 |
Sanford Burnham Prebys Medical Discovery Institute |
Mark Mercola |
Disease Team Planning |
“Stem Cell Therapies for Heart Failure” |
$44,450 |
Children’s Hospital of Los Angeles |
Dr. Donald B. Kohn |
Disease Team Planning |
STEM CELL GENE THERAPY FOR SICKLE CELL DISEASE |
$12,131 |
University of California, Irvine |
Dr. Leslie M Thompson |
Disease Team Planning |
Huntington’s Disease Team |
$41,953 |
Cedars-Sinai Medical Center |
Dr. Eduardo Marbán |
Disease Team Planning |
{REDACTED} Heart Disease Regenerative Medicine Team Planning Award |
$38,980 |
UCSF Benioff Children’s Hospital Oakland |
Dr. Mark C. Walters M.D. |
Disease Team Planning |
CIRM Disease Team Planning Award |
$16,939 |
Ludwig Institute for Cancer Research |
Dr. Webster K. Cavenee |
Disease Team Planning |
Stem Cell-Mediated Oncocidal Therapy of Primary & Metastatic Brain Tumors |
$3,867 |
University of California, Irvine |
Dr. Henry John Klassen |
Disease Team Planning |
Stem cells for neuroprotection of photoreceptors in retinitis pigmentosa |
$23,537 |
Buck Institute for Age Research |
Dr. Xianmin Zeng |
Disease Team Planning |
Develop a cell replacement therapy for Parkinson’s disease using human embryonic stem cells |
$37,161 |
University of California, Los Angeles |
Dr. Irvin SY Chen |
Disease Team Planning |
Stem Cell Therapy for AIDS- Disease Team Planning |
$51,490 |
University of California, San Diego |
Lawrence Goldstein |
Disease Team Planning |
Human Stem Cell Approaches to Alzheimers Disease Therapies |
$55,000 |
Stanford University |
Dr. Thomas A. Rando MD, PhD |
Disease Team Planning |
Stem Cell Therapy for Muscular Dystrophy |
$0 |
ViaCyte, Inc. |
Dr. Emmanuel Edward Baetge |
Disease Team Planning |
Development of a Cell Replacement Therapy Product for Insulin Dependent Diabetes |
$48,950 |
Gladstone Institutes, J. David |
Dr. Deepak Srivastava |
Disease Team Planning |
Pluripotent Stem Cell–Based Therapy for Heart Disease |
$13,505 |
University of California, Los Angeles |
Dr. Stanley Thomas Carmichael |
Disease Team Planning |
Development of a Stem Cell Therapy to Promote Functional Recovery in Stroke |
$42,748 |
Salk Institute for Biological Studies |
Prof. Samuel Lawrence Pfaff |
Disease Team Planning |
Motor neuron diseases: Finding cures through basic, translational, and clinical collaboration |
$51,266 |
University of Southern California |
Dr. Mark S Humayun |
Disease Team Planning |
Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) |
$3,088 |
University of California, San Francisco |
Professor Jeffrey Charles Lotz |
Disease Team Planning |
A CIRM Disease Team for the Repair of Traumatically Injured and Arthritic Cartilage |
$33,172 |
University of Southern California |
Dr. David Timothy Woodley |
Disease Team Planning |
Clinical Regenerative Wound Healing With Stem Cells |
$33,626 |
University of California, San Francisco |
Dr. Jeffrey A Bluestone |
Disease Team Planning |
A CIRM Disease Team for the Treatment and Cure of Diabetes |
$55,000 |
University of Southern California |
Dr. Chrysostomos L. Max Nikias |
Major Facilities |
Broad CIRM Facility at USC |
$26,972,500 |
University of California, San Francisco |
Dr. A. Eugene Washington |
Major Facilities |
UCSF CIRM Building |
$34,862,400 |
University of California, Santa Cruz |
Margaret L. Delaney |
Major Facilities |
UC Santa Cruz IBSC Facility |
$7,191,950 |
University of California, Santa Barbara |
Glenn E Lucas |
Major Facilities |
UC Santa Barbara Bio Sciences II |
$3,205,800 |
University of California, Merced |
John O. White |
Major Facilities |
Stem Cell Instrumentation Foundry |
$4,341,321 |
University of California, Los Angeles |
Dr. Gene D. Block |
Major Facilities |
UCLA CIRM Institute |
$19,854,900 |
University of California, Irvine |
Dr. Michael V Drake |
Major Facilities |
UC Irvine CIRM Institute |
$27,156,000 |
University of California, Davis |
Dr. Larry N. Vanderhoef |
Major Facilities |
UC Davis CIRM Institute |
$20,082,400 |
University of California, Berkeley |
Dr. George W. Breslauer |
Major Facilities |
UC Berkeley CIRM Center of Excellence |
$20,183,500 |
Stanford University |
Dr. John L. Hennessy |
Major Facilities |
Stanford SIM1 Building |
$43,578,000 |
Sanford Consortium for Regenerative Medicine |
Edward Holmes |
Major Facilities |
Sanford Consortium for Regenerative Medicine |
$42,827,439 |
Buck Institute for Age Research |
Mary McEachron |
Major Facilities |
CIRM Center of Excellence at Buck Institute for Age Research |
$20,500,000 |
University of California, Los Angeles |
Dr. Bennett G Novitch |
Basic Biology V |
In vitro modeling of human motor neuron disease |
$1,148,758 |
Stanford University |
Dr. Helen M Blau |
Basic Biology V |
Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging |
$1,175,357 |
Stanford University |
Dr. Marius Wernig MD, PhD |
Basic Biology V |
Mechanisms of human induced neuronal cell reprogramming |
$1,178,370 |
University of California, Irvine |
Dr. Peter J Donovan |
Basic Biology V |
Non-invasive live imaging of stem cell signature metabolic states |
$516,366 |
Palo Alto Veterans Institute for Research |
Dr. Thomas A. Rando |
Basic Biology V |
Molecular regulation of stem cell potency |
$966,510 |
University of California, Merced |
Dr. Kara E McCloskey |
Basic Biology V |
Directed Differentiation of Specialized Endothelial Cells |
$475,686 |
University of California, San Francisco |
Dr. Valerie Marie Weaver |
Basic Biology V |
Biophysical Determinants of Early Embryonic Stem Cell Fate Specification |
$1,186,500 |
California Institute of Technology |
Dr. David Anthony Tirrell |
Basic Biology V |
Engineered matrices for control of lineage commitment in human pancreatic stem cells |
$526,896 |